Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Total Current Liabilities (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Total Current Liabilities for 3 consecutive years, with $44.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities fell 38.44% year-over-year to $44.6 million, compared with a TTM value of $44.6 million through Sep 2025, down 38.44%, and an annual FY2024 reading of $61.2 million, down 33.81% over the prior year.
  • Total Current Liabilities was $44.6 million for Q3 2025 at SBC Medical Group Holdings, down from $60.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $92.5 million in Q4 2023 and bottomed at $837051.0 in Q1 2023.
  • Average Total Current Liabilities over 3 years is $35.9 million, with a median of $44.6 million recorded in 2025.
  • The sharpest move saw Total Current Liabilities skyrocketed 2860.5% in 2024, then crashed 38.44% in 2025.
  • Year by year, Total Current Liabilities stood at $92.5 million in 2023, then crashed by 33.81% to $61.2 million in 2024, then decreased by 27.14% to $44.6 million in 2025.
  • Business Quant data shows Total Current Liabilities for SBC at $44.6 million in Q3 2025, $60.7 million in Q2 2025, and $48.5 million in Q1 2025.